Drug Safety

NIDA Director to Deliver Keynote; Innovative Toxicology Research to Feature at 2024 ACMT Annual Scientific Meeting and Symposia in Washington, DC

Retrieved on: 
Wednesday, January 17, 2024
AACT, PFAS, Drug Safety, Occupational medicine, Addiction medicine, Research, ASM, Senior counsel, Health, Opioid, Antidote, Challenge, American Academy, Society, IST, Naloxone, Society of Toxicology, Public, Red, Omni Shoreham Hotel, Equity, Nursing, ASAM, Adolescence, American College, Physician

This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.

Key Points: 
  • This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.
  • Please note that registration for individual symposia is separate from the three-day main meeting.
  • The 2024 ACMT Annual Scientific Meeting main program will initiate on Friday, April 12.
  • Register now for the 2024 ACMT Annual Scientific Meeting and Symposia.

Artificial Intelligence and Machine Learning Powered Signal Management Training Course: From Learning to Leading - Mastering AI and ML for Enhanced Drug Safety

Retrieved on: 
Friday, December 22, 2023
Knowledge, PV, Health care, Natural language processing, NLP, Artificial intelligence, Deep learning, Pharmacovigilance, Drug Safety, Machine learning, Software, Risk management, Connection, Medical device

DUBLIN, Dec. 22, 2023 /PRNewswire/ -- The "Artificial Intelligence and Machine Learning Powered Signal Management Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 22, 2023 /PRNewswire/ -- The "Artificial Intelligence and Machine Learning Powered Signal Management Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • The quest to find precise evidence to answer complex questions from biomedicine and Healthcare for Drug Safety has brought us to a major crossroads.
  • Data (Information), Connection (Knowledge) and the Tools (Software) designed to deliver these answers is the future of Drug Safety.
  • This course will prepare you to navigate the multiverse of AI, ML and Deep Learning from a drug safety perspective with an easily understandable and practical approach.

Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding

Retrieved on: 
Tuesday, October 17, 2023
COVID-19, Drug Safety, American College of Medical Toxicology, Research, Toxicity, American College, Medicine, Drug overdose, Plasma protein binding, Patient, FDA, Abuse, DOTS, Maintenance, Drug, DO, Physician, Pharmaceutical industry, Education

This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.

Key Points: 
  • This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.
  • Comprehensive laboratory testing of the samples is conducted by the Center for Forensic Science Research and Education (CFSRE) .
  • CSFRE testing methods facilitate detection of over one thousand analytes (prescription drugs and illicit substances, including novel emerging substances).
  • Led by medical toxicology physicians and registry experts, our projects involve case registry design and maintenance.

Fentanyl, Xylazine, Cannabinoids to Feature in Virtual Forensic Toxicology Seminar December 14 - 15, 2023

Retrieved on: 
Monday, October 16, 2023
NMS, Physician, Highway patrol, Lab, Doctor of Philosophy, Drug Safety, American College of Medical Toxicology, Maastricht University, American College, Medicine, Q & A, Road, Continuing medical education, CME, Xylazine, Benzodiazepine, Fentanyl, Science and technology in Asia, Emergency, Cannabis, Harm reduction, Law enforcement, FSB Criminalistics Institute, Worlds, Legal nurse consultant, State, Research, The central science, NPS, Management, Nursing, Education, Cannabinoid, Psychopharmacology

The program opens with “Cannabis and the Expanding World of Cannabinoids” on Thursday, December 14th.

Key Points: 
  • The program opens with “Cannabis and the Expanding World of Cannabinoids” on Thursday, December 14th.
  • Topics covered include the legalization of cannabis, challenges with prosecuting marijuana DUIs, and the rise in use and adverse events with cannabinoid products.
  • The seminar will also explore the landscape of new psychoactive substances (NPS), drug delivery homicide cases, and advancements in clinical toxicology testing.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project

Retrieved on: 
Monday, October 2, 2023
Maintenance, Medicine, Drug Safety, BAA, Research, EMS, Abuse, MD, Patient, Physician, Emergency medical services, Toxicity, American College of Medical Toxicology, American College, FDA, Pharmaceutical industry, Nursing, Naloxone

This 4-year (base and 3 option years) project, titled “ Real-World Examination of Naloxone for Drug Overdose Reversal (RENDOR) ,” will study out-of-hospital naloxone administration through a collaboration with EMS agencies in San Francisco, CA; Detroit, MI; Portland, OR; and Pittsburgh, PA.

Key Points: 
  • This 4-year (base and 3 option years) project, titled “ Real-World Examination of Naloxone for Drug Overdose Reversal (RENDOR) ,” will study out-of-hospital naloxone administration through a collaboration with EMS agencies in San Francisco, CA; Detroit, MI; Portland, OR; and Pittsburgh, PA.
  • ACMT’s Board President, Anthony Pizon, MD, FACMT states, “The RENDOR project aims for a better understanding of how naloxone is being used now that it has been made more accessible and widely available.
  • ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.
  • Led by medical toxicology physicians and registry experts, our projects involve case registry design and maintenance.

Fluree Announces Partnership with Vitality TechNet to Enable Pharmaceutical Regulatory Information Management and Accelerate Drug Discovery

Retrieved on: 
Tuesday, August 15, 2023
Software, Pharmaceutical, Health, Artificial Intelligence, Data Management, Web3, Technology, Security, European Medicines Agency, Data management, Partnership, Probability, ISO, Data, RIM, Multimedia, EMA, Organization, SR, Drug Safety, Insurance Regulatory Information System, Drug discovery, Semantics, FDA, Vitality, Synovial joint, Pharmaceutical industry, Medical device

Fluree , which has developed a knowledge graph database and semantic data pipeline toolset for secure and trusted data sharing, today announced a partnership with Vitality TechNet to build a semantic data infrastructure for pharmaceutical organizations looking to enable digital Regulatory Information Management and accelerate drug discovery.

Key Points: 
  • Fluree , which has developed a knowledge graph database and semantic data pipeline toolset for secure and trusted data sharing, today announced a partnership with Vitality TechNet to build a semantic data infrastructure for pharmaceutical organizations looking to enable digital Regulatory Information Management and accelerate drug discovery.
  • Fluree provides first-class data security, audit and sharing capabilities needed by pharma organizations as they look to implement IDMP standards and build data collaboration platforms.
  • “Fluree is a perfect fit for pharmaceutical organizations seeking to balance regulatory compliance with innovation and accelerate drug discovery, efficacy and efficiency,” said Eliud Polanco, Fluree president.
  • Through this partnership, Fluree and Vitality TechNet will enable RIM (Regulatory Information Management) functions to reduce error in regulatory submissions, streamline the identification of potential risks and enhance safety monitoring.

Artificial Intelligence and Machine Learning Powered Signal Management Training: A Course for Visionaries - Unlocking the Potential of AI and ML in Drug Safety - ResearchAndMarkets.com

Retrieved on: 
Friday, August 11, 2023
Education, Health, Technology, Health Technology, Artificial Intelligence, Training, Knowledge, Natural language processing, Pharmacovigilance, Health care, Risk management, ML, Software, NLP, PV, Drug Safety, Machine learning, Artificial intelligence, Deep learning, Connection, Medical device, Nervous system, AI

The "Artificial Intelligence and Machine Learning Powered Signal Management Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Artificial Intelligence and Machine Learning Powered Signal Management Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • The quest to find precise evidence to answer complex questions from biomedicine and Healthcare for Drug Safety has brought us to a major crossroads.
  • Data (Information), Connection (Knowledge) and the Tools (Software) designed to deliver these answers is the future of Drug Safety.
  • This course will prepare you to navigate the multiverse of AI, ML and Deep Learning from a drug safety perspective with an easily understandable and practical approach.

Clinigen divests global rights to four cancer support therapies to CNX Therapeutics

Retrieved on: 
Thursday, August 10, 2023
Pharmaceutical Services Negotiating Committee, Heart, Laboratory, Radiation, Cancer, Greenhill & Co., Woman, Head, Cisplatin, Sale, Iovance Biotherapeutics, CNX, Patient, Drug Safety, Doxorubicin, Cardiomyopathy, Anthracycline, Therapy, Pharmaceutical industry, Fine chemical

Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the divestment of four cancer supportive care products from its established brands portfolio to CNX Therapeutics, a speciality pharmaceutical company with a focus on improving access to medicines that are critical to the well-being of patients.

Key Points: 
  • Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the divestment of four cancer supportive care products from its established brands portfolio to CNX Therapeutics, a speciality pharmaceutical company with a focus on improving access to medicines that are critical to the well-being of patients.
  • Cardioxane®, used in adults with advanced or metastatic breast cancer to prevent long-term harmful effects on the heart caused by treatment with certain anthracyclines.
  • Savene®, used to treat anthracycline extravasation in adults, a rare condition that can impact cancer patients.
  • Totect®, used for the treatment of anthracycline extravasation as well as for preventing cardiomyopathy associated with doxorubicin in women with metastatic breast cancer.

CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends

Retrieved on: 
Friday, June 9, 2023
Maintenance, Xylazine, Methamphetamine, Icahn School of Medicine at Mount Sinai, Principal investigator, Drug Safety, Fentanyl, Toxicology, Research, Risk, Mount Sinai, Heroin, CDC, Abuse, Hospital, Cocaine, Patient, Physician, NIDA, Drug, Toxicity, American College of Medical Toxicology, American College, Medical device, Pharmaceutical industry, Education

In response to this growing crisis, the CDC has collaborated with ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard that captures real-time data on nonfatal overdoses involving fentanyl.

Key Points: 
  • In response to this growing crisis, the CDC has collaborated with ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard that captures real-time data on nonfatal overdoses involving fentanyl.
  • The new dashboard, “Fentalog Study: A Subset of Nonfatal Suspected Opioid-Involved Overdoses with Toxicology Testing” went live in May of 2023.
  • It examines the clinical effects of fentanyl analogs among suspected opioid overdoses and utilizes ToxIC's extensive network of healthcare facilities to aggregate and analyze nonfatal overdose data.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Best Practices in Safety Signal Analytics -- Managing Today and Preparing for Tomorrow, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, March 28, 2023
Real-World Evidence, Product management, Scott Richter, Drug Safety, FDA, Real world data, Safety, Television, Pharmacovigilance

TORONTO, March 28, 2023 /PRNewswire-PRWeb/ -- With safety signal case volumes increasing 30 to 50 percent annually, how are pharmacovigilance teams managing with today's constrained budgets, and what can real-world data and advanced cognitive computing do for tomorrow?

Key Points: 
  • In this free webinar, learn from top pharmacovigilance professionals and engage in this invaluable conversation on the challenges, successes, and future innovations relevant to safety signal analytics.
  • Attendees will learn how real-world data and advanced cognitive computing are creating innovations now and in the future for safety signal analytics.
  • This webinar will feature pharmacovigilance industry experts from across life sciences as they discuss:
    What trends and challenges are safety signal teams facing today and how are they currently managing these issues?
  • With 70% of biopharma seeing a maturity gap in safety signal analytics processing, what feasible steps will be taken toward improving safety signal analytics this year?